PL88703B1 - - Google Patents

Download PDF

Info

Publication number
PL88703B1
PL88703B1 PL1974169031A PL16903174A PL88703B1 PL 88703 B1 PL88703 B1 PL 88703B1 PL 1974169031 A PL1974169031 A PL 1974169031A PL 16903174 A PL16903174 A PL 16903174A PL 88703 B1 PL88703 B1 PL 88703B1
Authority
PL
Poland
Prior art keywords
hours
virus
ethyleneimine
animals
bacteria
Prior art date
Application number
PL1974169031A
Other languages
English (en)
Polish (pl)
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of PL88703B1 publication Critical patent/PL88703B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32111—Aphthovirus, e.g. footandmouth disease virus
    • C12N2770/32161—Methods of inactivation or attenuation
    • C12N2770/32163—Methods of inactivation or attenuation by chemical treatment

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PL1974169031A 1973-02-24 1974-02-23 PL88703B1 (cs)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2309329A DE2309329C2 (de) 1973-02-24 1973-02-24 Verwendung von Äthyleniminlösungen als Inaktivierungsmittel bei der Herstellung von Impfstoffen

Publications (1)

Publication Number Publication Date
PL88703B1 true PL88703B1 (cs) 1976-09-30

Family

ID=5873014

Family Applications (1)

Application Number Title Priority Date Filing Date
PL1974169031A PL88703B1 (cs) 1973-02-24 1974-02-23

Country Status (11)

Country Link
BR (1) BR7401197D0 (cs)
CA (1) CA1038757A (cs)
CS (1) CS191909B2 (cs)
DE (1) DE2309329C2 (cs)
DK (1) DK132766C (cs)
ES (1) ES423617A1 (cs)
FR (1) FR2230346A1 (cs)
HU (1) HU171544B (cs)
IN (1) IN139338B (cs)
PL (1) PL88703B1 (cs)
RO (1) RO64304A (cs)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU78955A1 (de) * 1978-01-27 1979-09-06 Chimicasa Gmbh Verfahren zur inaktivierung von viren

Also Published As

Publication number Publication date
DK132766C (da) 1976-07-05
ES423617A1 (es) 1976-11-01
DE2309329C2 (de) 1983-05-11
HU171544B (hu) 1978-02-28
DK132766B (da) 1976-02-02
FR2230346B1 (cs) 1977-11-04
BR7401197D0 (pt) 1974-11-05
DE2309329A1 (de) 1974-08-29
RO64304A (fr) 1978-08-15
CS191909B2 (en) 1979-07-31
FR2230346A1 (en) 1974-12-20
IN139338B (cs) 1976-06-05
CA1038757A (en) 1978-09-19

Similar Documents

Publication Publication Date Title
DE69227400T2 (de) Impfstoffe und Verfahren zu ihrer Herstellung
Isaacs et al. Virus interference. I. The interferon
CN111315362A (zh) 纳米结构脂质载剂和稳定乳剂以及其用途
Rockborn Canine distemper virus in tissue culture
EP0036077B1 (en) Esters of hydroxylalkyl-purines, processes for preparing them and therapeutical composition containing these esters as active ingredients
US20040253272A1 (en) Process for producing inactivated virus envelopes
US4058599A (en) Ethyleneimine inactivated organisms
US4036952A (en) Ethyleneimine inactivated microorganisms
US3636196A (en) Ethylethyleneimine as an inactivation agent
Henle et al. Neurological signs in mice following intracerebral inoculation of influenza viruses
Hart et al. Interactions of ribonucleotide polymers with tobacco mosaic virus protein to form virus-like particles
Davenport Toxicity of NDV for mouse lungs
US3354038A (en) Serial passaging tissue cultured canine distemper virus to form attenuated vaccine short of virus-antigenicity decreasing passages
Smorodintsev Basic mechanisms of nonspecific resistance to viruses in animals and man
Hess et al. Some properties of the virus of duck plague
US4386065A (en) Vaccine against EAE
PL88703B1 (cs)
US3981772A (en) Method of attenuating viruses with simultaneous stabilization of their antigens using selected aminomethylol compounds
PL156487B1 (pl) Sposób prowadzenia hodowli Treponema hyodysenteriae PL PL PL
CN112941145B (zh) 一种包膜病毒及病原细菌的灭活试剂及其应用
US3000788A (en) Propagation of modified infectious canine hepatitis virus in tissue cultures of pig kidney and the preparation of a vaccine therefrom
US3470294A (en) Vaccine for immunization of dogs and foxes against distemper,hepatitis contagiosa and leptospirosis and process for preparing it
US4312947A (en) Process for the preparation of a vaccine against panleucopenia of the cat
Fulton Toxic exudates in Toxoplasma gondii infections
KR20010083916A (ko) 감독화톡신을 포함하는 백신제제